Monocyte-to-HDL cholesterol ratio and cardiovascular comorbidity in COPD: Evidence from NHANES 2007 to 2018.

Zhu C, Luan C, Chu Y

Open source

DOI
10.1097/md.0000000000050756
Published
2026 Sep 18
Container
Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050756,
  title = {Monocyte-to-HDL cholesterol ratio and cardiovascular comorbidity in COPD: Evidence from NHANES 2007 to 2018.},
  author = {Zhu C and Luan C and Chu Y},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050756},
  url = {https://doi.org/10.1097/md.0000000000050756}
}

RIS

TY  - JOUR
TI  - Monocyte-to-HDL cholesterol ratio and cardiovascular comorbidity in COPD: Evidence from NHANES 2007 to 2018.
AU  - Zhu C
AU  - Luan C
AU  - Chu Y
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050756
UR  - https://doi.org/10.1097/md.0000000000050756
ER  - 

APA

C, Z., C, L., & Y, C. (2026). Monocyte-to-HDL cholesterol ratio and cardiovascular comorbidity in COPD: Evidence from NHANES 2007 to 2018.. Medicine. https://doi.org/10.1097/md.0000000000050756

Source records